Quest Diagnostics
517 hedge funds and large institutions have $9.72B invested in Quest Diagnostics in 2014 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 180 increasing their positions, 172 reducing their positions, and 43 closing their positions.
93% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 43
88% more funds holding in top 10
Funds holding in top 10: 8 → 15 (+7)
7% more funds holding
Funds holding: 485 → 517 (+32)
5% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 172
8% less capital inflows, than outflows
Capital inflows: $1.13B | Capital outflows: $1.23B
1.55% less ownership
Funds ownership: 101.82% → 100.27% (-1.5%)
75% less call options, than puts
Call options by funds: $62.4M | Put options by funds: $250M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$149M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
+$111M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$88M |
| 4 |
Millennium Management
New York
|
+$76.4M |
| 5 |
Renaissance Technologies
New York
|
+$53.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$283M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$127M |
| 3 |
T
TOBAM
Paris,
France
|
-$109M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$106M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$53.3M |
DGX Hedge Fund Activity: Q4 2014 in Review
517 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2014, worth a combined $9.72B — up 9% from $8.92B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new DGX positions and 43 closed out — a net gain of 40 holders — while 180 added to existing stakes and 172 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $149M. The largest seller was Bank of America, cutting an estimated $283M.
- 517 institutional investors held Quest Diagnostics (DGX) as of Q4 2014, up from 485 in Q3 2014.
- Funds reported $9.72B of Quest Diagnostics stock for Q4 2014, up 9% quarter-over-quarter.
- 83 funds opened new Quest Diagnostics positions in Q4 2014 and 43 closed out, a net change of +40 holders.
- The largest Quest Diagnostics buyer in Q4 2014 was Citadel Advisors, an estimated $149M added.
- The largest Quest Diagnostics seller in Q4 2014 was Bank of America, an estimated $283M sold.
Based on aggregated 13F filings for Q4 2014.